• 作者：C.I. Daï ; en^a ; P. Fesler^b ; ^{p-fesler@chu-montpellier.fr}
• 关键词：Polyarthrite rhumatoï ; de ; Maladies cardiovasculaires
• 刊名：Annales de Cardiologie et d'Angeiologie
• 出版年：2012
• 期刊代码：274_00033928
• 类别：med
• 出版时间：April, 2012
• 卷：61
• 期：2
• 页码：111-117
• 文件大小：259 K

Mortality in rheumatoid arthritis (RA) is doubled when compared to the general population. This excess in mortality can be explained in half of cases by cardiovascular (CV) events. The risk of myocardial infarction is increased by about 60%in RA. Mortality secondary to cerebrovascular stroke is increased by 50%even if the incidence of stroke is not increased. Indeed, the risk of fatal CV events is increased in RA when compared to the general population. The increased CV risk cannot be explained only by traditional CV risk factors, even if smoking and changes in lipid profile may be implied. It is mainly related to the chronic inflammatory condition that causes many metabolic disturbances. Other parameters such as treatments used in RA also play a role. Thus, it is essential for proper management of RA patients to be aware of this risk and to treat any modifiable CV risk factors.